gip/glp-1 agonist GLP-1 & GIP Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic
Description
1 Study Design
Its tempting to view a drug like a shortcut, especially when everyone seems to be talking about it
2025, doi: 10.1111/dom.16661
GLP-1RAs may improve endothelial cell function via anti-inflammatory and vasodilatory properties
Some analyses from these trials showed modest reductions in inflammatory biomarkers, including high-sensitivity C-reactive protein (hs-CRP)
